Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 82

1.

Meeting Report: WHO consultation on considerations for regulatory expectations of Zika virus vaccines for use during an emergency.

Vannice KS, Giersing BK, Kaslow DC, Griffiths E, Meyer H, Barrett A, Durbin AP, Wood D, Hombach J.

Vaccine. 2016 Dec 1. pii: S0264-410X(16)30969-0. doi: 10.1016/j.vaccine.2016.10.034. [Epub ahead of print]

PMID:
27916410
2.

Developing a vaccine against Zika.

Hombach J, Friede M, Moorphy V, Costello A, Kieny MP.

BMJ. 2016 Nov 10;355:i5923. doi: 10.1136/bmj.i5923. No abstract available.

3.

A global review of national influenza immunization policies: Analysis of the 2014 WHO/UNICEF Joint Reporting Form on immunization.

Ortiz JR, Perut M, Dumolard L, Wijesinghe PR, Jorgensen P, Ropero AM, Danovaro-Holliday MC, Heffelfinger JD, Tevi-Benissan C, Teleb NA, Lambach P, Hombach J.

Vaccine. 2016 Oct 26;34(45):5400-5405. doi: 10.1016/j.vaccine.2016.07.045. Review.

4.

Review of prescribing information for influenza vaccines for pregnant and lactating women.

Proveaux T, Lambach P, Ortiz JR, Hombach J, Halsey NA.

Vaccine. 2016 Oct 26;34(45):5406-5409. doi: 10.1016/j.vaccine.2016.08.042. Review.

5.

Population Perspectives and World Health Organization Recommendations for CYD-TDV Dengue Vaccine.

Wilder-Smith A, Vannice KS, Hombach J, Farrar J, Nolan T.

J Infect Dis. 2016 Dec 15;214(12):1796-1799. No abstract available.

PMID:
27496977
6.

Assessing dengue vaccination impact: Model challenges and future directions.

Recker M, Vannice K, Hombach J, Jit M, Simmons CP.

Vaccine. 2016 Aug 31;34(38):4461-5. doi: 10.1016/j.vaccine.2016.06.082.

7.

Quantifying the Epidemiological Impact of Vector Control on Dengue.

Reiner RC Jr, Achee N, Barrera R, Burkot TR, Chadee DD, Devine GJ, Endy T, Gubler D, Hombach J, Kleinschmidt I, Lenhart A, Lindsay SW, Longini I, Mondy M, Morrison AC, Perkins TA, Vazquez-Prokopec G, Reiter P, Ritchie SA, Smith DL, Strickman D, Scott TW.

PLoS Negl Trop Dis. 2016 May 26;10(5):e0004588. doi: 10.1371/journal.pntd.0004588. No abstract available.

8.

Status of vaccine research and development of vaccines for dengue.

Vannice KS, Durbin A, Hombach J.

Vaccine. 2016 Jun 3;34(26):2934-8. doi: 10.1016/j.vaccine.2015.12.073.

9.

What Have We Learned From the Typhoid Fever Surveillance in Africa Program?

Baker S, Hombach J, Marks F.

Clin Infect Dis. 2016 Mar 15;62 Suppl 1:S1-3. doi: 10.1093/cid/civ675.

10.

Global Vaccine and Immunization Research Forum: Opportunities and challenges in vaccine discovery, development, and delivery.

Ford AQ, Touchette N, Hall BF, Hwang A, Hombach J.

Vaccine. 2016 Mar 18;34(13):1489-95. doi: 10.1016/j.vaccine.2015.11.038.

PMID:
26626210
11.

Report on the second WHO integrated meeting on development and clinical trials of influenza vaccines that induce broadly protective and long-lasting immune responses: Geneva, Switzerland, 5-7 May 2014.

Cox NJ, Hickling J, Jones R, Rimmelzwaan GF, Lambert LC, Boslego J, Rudenko L, Yeolekar L, Robertson JS, Hombach J, Ortiz JR.

Vaccine. 2015 Nov 27;33(48):6503-10. doi: 10.1016/j.vaccine.2015.10.014.

PMID:
26478203
12.

Next generation dengue vaccines: A review of the preclinical development pipeline.

Vannice KS, Roehrig JT, Hombach J.

Vaccine. 2015 Dec 10;33(50):7091-9. doi: 10.1016/j.vaccine.2015.09.053. Review.

13.

Considerations of strategies to provide influenza vaccine year round.

Lambach P, Alvarez AM, Hirve S, Ortiz JR, Hombach J, Verweij M, Hendriks J, Palkonyay L, Pfleiderer M.

Vaccine. 2015 Nov 25;33(47):6493-8. doi: 10.1016/j.vaccine.2015.08.037. Review.

14.

A global perspective of maternal influenza immunization.

Lambach P, Hombach J, Ortiz JR.

Vaccine. 2015 Nov 25;33(47):6376-9. doi: 10.1016/j.vaccine.2015.08.036. Review. No abstract available.

15.

Gender Determinants of Vaccination Status in Children: Evidence from a Meta-Ethnographic Systematic Review.

Merten S, Martin Hilber A, Biaggi C, Secula F, Bosch-Capblanch X, Namgyal P, Hombach J.

PLoS One. 2015 Aug 28;10(8):e0135222. doi: 10.1371/journal.pone.0135222. Review.

16.

New chapter unfolding in the fight against dengue with an unwritten ending.

Thiry G, Hombach J, Constenla D, Carvalho A, Durbin A.

Trans R Soc Trop Med Hyg. 2014 Oct;108(10):597-8. doi: 10.1093/trstmh/tru149. No abstract available.

PMID:
25217182
17.

Group A streptococcal vaccines: paving a path for accelerated development.

Dale JB, Fischetti VA, Carapetis JR, Steer AC, Sow S, Kumar R, Mayosi BM, Rubin FA, Mulholland K, Hombach JM, Schödel F, Henao-Restrepo AM.

Vaccine. 2013 Apr 18;31 Suppl 2:B216-22. doi: 10.1016/j.vaccine.2012.09.045. Review.

PMID:
23598485
18.

The need for targeted implementation research to improve coverage of basic vaccines and introduction of new vaccines.

Arora NK, Lal AA, Hombach JM, Santos JI, Bhutta ZA, Sow SO, Greenwood B.

Vaccine. 2013 Apr 18;31 Suppl 2:B129-36. doi: 10.1016/j.vaccine.2013.01.058. Review.

PMID:
23598474
19.

Long-term safety assessment of live attenuated tetravalent dengue vaccines: deliberations from a WHO technical consultation.

Live Dengue Vaccines Technical Consultation Reporting Group., Bentsi-Enchill AD, Schmitz J, Edelman R, Durbin A, Roehrig JT, Smith PG, Hombach J, Farrar J.

Vaccine. 2013 May 28;31(23):2603-9. doi: 10.1016/j.vaccine.2013.03.038.

20.

Decision-making on malaria vaccine introduction: the role of cost-effectiveness analyses.

Moorthy VS, Hutubessy R, Newman RD, Hombach J.

Bull World Health Organ. 2012 Nov 1;90(11):864-6. doi: 10.2471/BLT.12.107482. No abstract available.

Items per page

Supplemental Content

Loading ...
Support Center